WHO secret laboratory in Spiez: revelations and unanswered questions
The WHO BioHub laboratory in Spiez, Switzerland, has been causing controversy for some time. Christian Oesch, a member of the non-profit organisation “Wir”, and his team have conducted research that raises controversial questions about the function and transparency of this laboratory. In an interview, Oesch sheds light on the background and uncovers possible links to international health regulations (IHR) and global power structures. Here is an overview of the most important findings.
you can Switch to English in “parameters”
Discovery of the WHO BioHub in Spiez
Oesch and his team became aware of the WHO BioHub in early 2023 when they were working on the international health regulations and the WHO pandemic treaty. A WHO document pointed to the laboratory in Spiez as the central location for a global system for the distribution of pathogens.
What is particularly striking is that the laboratory was set up without broad public discussion, which raises questions about transparency. “Why is there hardly any critical reporting on this in Switzerland?” asks Oesch, speaking of a “media blackout”.
History and function of the Spiez Laboratory
The Spiez Laboratory has its roots in the response to chemical weapons during the First World War and was founded in 1925 as a federal institute for protection against NBC (nuclear, biological, chemical) hazards. In the 1940s and 1950s, it was expanded to include chemical and nuclear protection functions, followed by an upgrade to the highest biosafety level (BSL-4) in 2010.
Today, the laboratory carries out analyses and diagnostics of highly pathogenic agents and toxins, produces small quantities of chemical warfare agents for reference purposes and tests protection systems against CBRNE threats (chemical, biological, radiological, nuclear, explosive).
Since May 2021, the laboratory has functioned as a WHO BioHub, a central hub for the storage, characterisation and global distribution of pathogens with epidemic or pandemic potential. Officially, this is intended to speed up the exchange of pathogens for research, diagnostics and vaccine development.
But Oesch sees more to it than that: “The laboratory cultivates and optimises living pathogens, stores them at -80 °C and distributes them worldwide. The data, including genome sequences, are stored in WHO databases.”
He is concerned about the lack of parliamentary oversight in Switzerland and the link to controversial gain-of-function research, which can make pathogens more infectious or more resistant in a targeted manner.
Lack of transparency and late communication
Spiez Laboratory only published a notice about the WHO BioHub on 20 June 2025, even though it has been in existence since 2021. “This late communication raises questions,” says Oesch.
He suspects that information was deliberately withheld, possibly to protect the company’s reputation or to avoid criticism. The Swiss population and parliament were not asked whether they support a global centre for high-risk pathogens on their soil. Oesch sees this as a “transparency at the last minute” principle.
Mysterious spider threads and bioweapons
Another topic that Oesch’s team is investigating is mysterious white threads that have been found in gardens in Central Europe and resemble spider webs.
Laboratory tests have shown that these threads contain cavities filled with over 50 substances, including toxic substances. Some substances are not even registered in international databases.
Patents from 2013 indicate that such threads were developed for applications in agriculture, medicine or biology. Oesch suspects that they could be distributed by drones or aeroplanes and speaks of possible links to bioweapons development.
The association asked the Swiss Federal Council for clarification, but was met with rejection.
Connections to international organisations
The Spiez Laboratory is closely linked to the Inselspital Bern, where patients release their biological samples for research purposes by means of “General Consent” forms. These samples, including genetic data, can be passed on to international partners without revocation.
Since 2021, Inselspital has been operating a BSL-3 biobank that creates synthetic genomes of high-risk pathogens. Oesch sees this as a “biopolitical nerve centre” that operates without democratic legitimacy.
Switzerland, as the headquarters of the WHO, GAVI (Global Alliance for Vaccination) and other international organisations, enjoys a special position. These organisations are protected by diplomatic immunity from Swiss jurisdiction, which makes monitoring more difficult.
Oesch criticises the fact that the WHO is circumventing democratic controls with the BioHub and the new International Health Regulations (IHR), which were adopted by the Federal Council on 20 June 2025 without the involvement of Parliament.
A petition with almost 50,000 signatures and over 1,800 submissions in the consultation procedure were ignored.
Gain-of-function research and bioweapons
Gain-of-function research, which can specifically make pathogens more dangerous, is permitted in Switzerland, but is subject to strict conditions.
Oesch fears that the Spiez laboratory could be used as neutral ground for such experiments. He refers to biolaboratories in Ukraine that were financed by the USA and speculates that high-risk pathogens could be outsourced to Switzerland.
“Switzerland could become a hub for bioweapons,” he warns.
International Cooperation and Dr Mary Nass
Oesch works with Dr Mary Nass, a US expert on biological warfare who is associated with Robert F. Kennedy Jr. Nass has worked intensively with the WHO and the BioHub.
Oesch hopes that this collaboration will draw international attention to Spiez, especially as the USA has cut WHO funding and wants to stop gain-of-function research.
“We want to bring the wave from abroad to Switzerland,” says Oesch.
Conclusion: A global power play?
Oesch does not see the WHO BioHub as a pure research project, but as a “strategic hub in the global power game for health and control”.
The most recent amendment to the Medicinal Products Licensing Ordinance (AMBVau) of March 2025 allows international organisations such as the WHO to import medicinal products uncontrolled, without liability or democratic control.
This is reminiscent of the GAVI model, which, according to Oesch, distributes billions of vaccine doses to developing countries without sufficient regulation.
“It’s not about health, but about power, the market and the creeping erosion of democratic control,” summarises Oesch.
His organisation plans to continue exerting pressure, possibly through a referendum on the Epidemics Act. According to Oesch, Switzerland must regain its sovereignty so that it no longer serves as an “enforcer” of global power structures.
Further information on the “Wir” association’s research can be found on the vereinwir.ch website, in particular under the heading “Spinnenfäden”.
